wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41849636-653E2381-A79F-41C4-9E9C-42C5EA86D7BC
Q41849636-653E2381-A79F-41C4-9E9C-42C5EA86D7BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41849636-653E2381-A79F-41C4-9E9C-42C5EA86D7BC
Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies.
P2860
Q41849636-653E2381-A79F-41C4-9E9C-42C5EA86D7BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41849636-653E2381-A79F-41C4-9E9C-42C5EA86D7BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0719b72c5f43d958df6fb3068c7e893ae78282b3
P2860
Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma.